Vitamin B12 and Cancer Risk — Why More Is Not Always Better
New research suggests both low and high B12 levels may raise cancer risk, challenging the idea that extra supplementation is always safe.
Summary
Vitamin B12 is essential for DNA repair, red blood cell production, and nerve health — but emerging research is complicating the simple 'more is better' narrative. A 2025 Vietnamese case-control study found a U-shaped relationship between B12 intake and cancer risk, meaning both deficiency and excess were linked to higher risk. High-dose B12 supplements have not been shown to protect against cancer overall, and some studies suggest a slight increase in lung cancer risk among long-term, high-dose users — particularly men and smokers. Researchers also note that elevated B12 in cancer patients may reflect the disease itself rather than a cause. For most healthy adults, balance through diet remains the safest approach.
Detailed Summary
Vitamin B12 has long been celebrated as a nutritional essential, critical for DNA replication, red blood cell formation, and nervous system health. But a growing body of research is prompting scientists to ask harder questions about whether high-dose supplementation truly benefits health — or could, in some contexts, cause harm.
A 2025 case-control study from Vietnam identified a U-shaped relationship between B12 intake and cancer risk. Both low and high B12 intake were associated with elevated cancer risk, suggesting that optimal intake exists within a defined range. While this type of observational study cannot establish cause and effect, it adds to a pattern of evidence suggesting that extremes in either direction carry risk.
The biological concern with very high B12 centers on cell growth. B12 supports DNA synthesis and cell division broadly — not selectively in healthy cells. In theory, if pre-cancerous cells are already present, an abundance of growth-supporting nutrients could accelerate their development. This remains difficult to definitively prove in human studies, but the hypothesis is scientifically plausible.
Long-term, high-dose B vitamin supplementation has not demonstrated consistent cancer-protective effects in clinical research. Some observational data point to a modest increase in lung cancer risk associated with high-dose B6 and B12 use, especially in male smokers. Meanwhile, elevated blood B12 commonly seen in cancer patients appears to be a consequence of the disease — an epiphenomenon — rather than a driver, according to a 2022 analysis.
The practical message for health-conscious adults is one of calibration rather than fear. People at genuine risk of deficiency — vegans, older adults, those with gut absorption issues — still benefit from supplementation. But routine high-dose B12 supplementation without confirmed deficiency lacks strong evidence of benefit and may carry underappreciated risks worth discussing with a clinician.
Key Findings
- A 2025 study found both low and high B12 intake linked to increased cancer risk in a U-shaped pattern.
- High-dose B12 supplements show no consistent protective effect against cancer incidence or cancer mortality.
- Some observational data link long-term high-dose B6 and B12 use to slightly elevated lung cancer risk in men and smokers.
- Elevated B12 blood levels in cancer patients likely reflect the disease process, not a causal factor.
- Deficiency remains a real concern for vegans, older adults, and those with gut absorption conditions.
Methodology
This is a science news summary sourced from The Conversation, a credible outlet publishing academic expert commentary. Evidence cited includes a 2025 case-control study, a 2022 research analysis, and multiple observational studies. The article accurately notes the limitations of observational research in establishing causation.
Study Limitations
The article is a summary of multiple studies with differing designs; no single primary study is fully detailed. Observational studies cited cannot confirm causation. Readers should consult original research and a healthcare provider before altering supplementation practices.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.